Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Words Matter, from Clinical Documentation to Case Reports

Philip Seo, MD, MHS  |  Issue: January 2018  |  January 19, 2018

The article was published on a Friday. By Saturday, people were already responding to the report. Rush Holt, CEO of the American Association for the Advancement of Science, commented, “Among the words forbidden to be used in CDC budget documents are ‘evidence-based’ and ‘science-based.’ I suppose one must not think of those things either. Here’s a word that’s still allowed: ridiculous.”4

The Washington Post and other media outlets blandly noted that entire divisions within the CDC perform research that uses these words. It was not immediately clear, for example, how researchers could request additional funding for research on the Zika virus if they could not mention the impact of a maternal infection on the fetus. The most entertaining response came from Chuck Todd on NBC’s Meet the Press, who, riffing on George Carlin’s act, merely made a statement incorporating all seven words without further comment.5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How the CDC views language & words has the potential to affect all of us, both as rheumatologists & as beneficiaries of the CDC’s research in other fields.

Matt Lloyd, spokesperson for the Department of Health and Human Services, disagreed with the report. In a statement to CNN, he noted, “the assertion that HHS has ‘banned words’ is a complete mischaracterization of discussions regarding the budget formulation process. HHS will continue to use the best scientific evidence available to improve the health of all Americans. HHS also strongly encourages the use of outcome and evidence data in program evaluations and budget decisions.”6

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Brenda Fitzgerald, MD, director of the CDC, took to Twitter to state, “You may be understandably concerned about recent media reports alleging that [the] CDC is banned from using certain words in budget documents. I want to assure you that [the] CDC remains committed to our public health mission as a science and evidence-based institution.” After quoting Matt Lloyd’s statement, she went on to state, “I want to assure you there are no banned words at the CDC. We will continue to talk about all our important public health programs.”7

In Fiscal Year 2017, the CDC’s budget was $7.2 billion, $1.12 billion of which was dedicated to chronic disease prevention and health promotion.8 One of the chronic diseases the CDC has focused on is arthritis. The CDC collects data on the prevalence of arthritis in the U.S., and how arthritis affects patients’ quality of life. The CDC also supports efforts by state and national programs, such as the Osteoarthritis Action Alliance, to educate patients on the pathogenesis and prevention of osteoarthritis.9 How the CDC views language and words has the potential to affect all of us, both as rheumatologists and as beneficiaries of the CDC’s research in other fields.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:case reportclinical documentation

Related Articles

    2014 ACR/ARHP Annual Meeting: Evelyn V. Hess Award Presentation

    February 1, 2015

    The Lupus Foundation of America bestows awards to Drs. Jane Salmon, George Tsokos for outstanding contributions to research

    Disappearing Dollars

    October 1, 2007

    What’s happening to federal research funding in rheumatology?

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    How to Diagnose Upper Extremity Injuries

    February 13, 2020

    ATLANTA—Two ways to investigate injuries to the upper extremities are by in-depth physical examinations and ultrasound. In a Clinical Practice session at the 2019 ACR/ARP Annual Meeting, Anatomy: Correlating Physical Exam and Ultrasound in Common Sports Injuries of the Upper Extremity, Carlin Senter, MD, FACP, associate professor of primary care sports medicine at the University…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences